SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1476 5438 "

Sökning: L773:1476 5438

  • Resultat 41-50 av 373
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
41.
  • Corcia, Philippe, et al. (författare)
  • Homozygous SMN2 deletion is a protective factor in the Swedish ALS population
  • 2012
  • Ingår i: European Journal of Human Genetics. - : Springer Science and Business Media LLC. - 1018-4813 .- 1476-5438. ; 20:5, s. 588-591
  • Tidskriftsartikel (refereegranskat)abstract
    • Abnormal survival motor neuron 1 (SMN1)-copy number has been associated with an increased risk of amyotrophic lateral sclerosis (ALS) in French and Dutch population studies. The aim of this study was to determine whether SMN gene copy number increases the risk of ALS or modulates its phenotype in a cohort of Swedish sporadic ALS (SALS) patients. In all, 502 Swedes with SALS and 502 Swedish controls matched for gender and age were enrolled. SMN1 and SMN2 gene copy numbers were studied by a semi-quantitative PCR method. A genotype-phenotype comparison was performed in order to determine whether SMN genes modulate the phenotype of ALS. The results were also compared with our previously reported French cohort of ALS patients. There was no difference between Swedish patients and controls in the frequency of SMN1 and SMN2 copy numbers. The frequency of SMN1 gene copies differed significantly between the French and Swedish ALS populations. The duration of the disease was significantly longer in the Swedish cohort with homozygous deletions of SMN2 when compared with the French cohort. Abnormal SMN1 gene copy number cannot be considered as a universal genetic susceptibility factor for SALS and this result underlines the importance of reproducing association gene studies in groups from different origins. We also suggest that SMN2 gene copy number might have different effects on ALS progression in disparate human populations. European Journal of Human Genetics (2012) 20, 588-591; doi:10.1038/ejhg.2011.255; published online 25 January 2012
  •  
42.
  • Cornel, Martina C., et al. (författare)
  • Moving towards a cure in genetics : what is needed to bring somatic gene therapy to the clinic?
  • 2019
  • Ingår i: European Journal of Human Genetics. - : NATURE PUBLISHING GROUP. - 1018-4813 .- 1476-5438. ; 27:3, s. 484-487
  • Tidskriftsartikel (refereegranskat)abstract
    • Clinical trials using somatic gene editing (e.g., CRISPR-Cas9) have started in Europe and the United States and may provide safe and effective treatment and cure, not only for cancers but also for some monogenic conditions. In a workshop at the 2018 European Human Genetics Conference, the challenges of bringing somatic gene editing therapies to the clinic were discussed. The regulatory process needs to be considered early in the clinical development pathway to produce the data necessary to support the approval by the European Medicines Agency. The roles and responsibilities for geneticists may include counselling to explain the treatment possibilities and safety interpretation.
  •  
43.
  • Danielsson, Marcus, et al. (författare)
  • Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals
  • 2020
  • Ingår i: European Journal of Human Genetics. - : Springer Science and Business Media LLC. - 1018-4813 .- 1476-5438. ; 28:3, s. 349-357
  • Tidskriftsartikel (refereegranskat)abstract
    • Mosaic loss of chromosome Y (LOY) is the most common somatic genetic aberration and is associated with increased risk for all-cause mortality, various forms of cancer and Alzheimer's disease, as well as other common human diseases. By tracking LOY frequencies in subjects from which blood samples have been serially collected up to five times during up to 22 years, we observed a pronounced intra-individual variation of changes in the frequency of LOY within individual men over time. We observed that in some individuals the frequency of LOY in blood clearly progressed over time and that in other men, the frequency was constant or showed other types of longitudinal development. The predominant method used for estimating LOY is calculation of the median Log R Ratio of probes located in the male specific part of chromosome Y (mLRRY) from intensity data generated by SNP-arrays, which is difficult to interpret due to its logarithmic and inversed scale. We present here a formula to transform mLRRY-values to percentage of LOY that is a more comprehensible unit. The formula was derived using measurements of LOY from matched samples analysed using SNP-array, whole genome sequencing and a new AMELX/AMELY-based assay for droplet digital PCR. The methods described could be applied for analyses of the vast amount of SNP-array data already generated in the scientific community, allowing further discoveries of LOY associated diseases and outcomes.
  •  
44.
  • Danielsson, Marcus, et al. (författare)
  • Reply to Veitia
  • 2021
  • Ingår i: European Journal of Human Genetics. - : Springer Nature. - 1018-4813 .- 1476-5438. ; 29:9, s. 1323-1324
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
45.
  •  
46.
  • Dareng, EO, et al. (författare)
  • Polygenic risk modeling for prediction of epithelial ovarian cancer risk
  • 2022
  • Ingår i: European journal of human genetics : EJHG. - : Springer Science and Business Media LLC. - 1476-5438 .- 1018-4813. ; 30:3, s. 349-362
  • Tidskriftsartikel (refereegranskat)abstract
    • Polygenic risk scores (PRS) for epithelial ovarian cancer (EOC) have the potential to improve risk stratification. Joint estimation of Single Nucleotide Polymorphism (SNP) effects in models could improve predictive performance over standard approaches of PRS construction. Here, we implemented computationally efficient, penalized, logistic regression models (lasso, elastic net, stepwise) to individual level genotype data and a Bayesian framework with continuous shrinkage, “select and shrink for summary statistics” (S4), to summary level data for epithelial non-mucinous ovarian cancer risk prediction. We developed the models in a dataset consisting of 23,564 non-mucinous EOC cases and 40,138 controls participating in the Ovarian Cancer Association Consortium (OCAC) and validated the best models in three populations of different ancestries: prospective data from 198,101 women of European ancestries; 7,669 women of East Asian ancestries; 1,072 women of African ancestries, and in 18,915 BRCA1 and 12,337 BRCA2 pathogenic variant carriers of European ancestries. In the external validation data, the model with the strongest association for non-mucinous EOC risk derived from the OCAC model development data was the S4 model (27,240 SNPs) with odds ratios (OR) of 1.38 (95% CI: 1.28–1.48, AUC: 0.588) per unit standard deviation, in women of European ancestries; 1.14 (95% CI: 1.08–1.19, AUC: 0.538) in women of East Asian ancestries; 1.38 (95% CI: 1.21–1.58, AUC: 0.593) in women of African ancestries; hazard ratios of 1.36 (95% CI: 1.29–1.43, AUC: 0.592) in BRCA1 pathogenic variant carriers and 1.49 (95% CI: 1.35–1.64, AUC: 0.624) in BRCA2 pathogenic variant carriers. Incorporation of the S4 PRS in risk prediction models for ovarian cancer may have clinical utility in ovarian cancer prevention programs.
  •  
47.
  • Darin, Niklas, 1964, et al. (författare)
  • γ-glutamyl transpeptidase deficiency caused by a large homozygous intragenic deletion in GGT1.
  • 2018
  • Ingår i: European journal of human genetics : EJHG. - : Springer Science and Business Media LLC. - 1476-5438 .- 1018-4813. ; 26, s. 808-817
  • Tidskriftsartikel (refereegranskat)abstract
    • γ-Glutamyl transpeptidase deficiency (glutathionuria, OMIM 231950) is a rare disease, with only six patients reported in the literature, although this condition has probably been underdiagnosed due the difficulty to routinely analyze glutathione in clinical samples and to the fact that no genetic defect has been coupled to the disease so far. We report two siblings with mild psychomotor developmental delay and mild neurological symptoms, who presented a markedly increased excretion of glutathione in urine and a very low γ-glutamyl transpeptidase activity in serum. Whole-genome sequencing revealed the presence of a 16.9kb homozygous deletion in GGT1, one of the genes encoding enzymes with γ-glutamyl transpeptidase activity in the human genome. Close analysis revealed the presence of a 13bp insertion at the deletion junction. This is the first report of a genetic variant as the cause of glutathionuria. In addition, genetic characterization of the patients' parents and a healthy sibling has provided direct genetic evidence regarding the autosomal recessive nature of this disease.
  •  
48.
  •  
49.
  • de Boer, E, et al. (författare)
  • A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis
  • 2021
  • Ingår i: European journal of human genetics : EJHG. - : Springer Science and Business Media LLC. - 1476-5438 .- 1018-4813. ; 29:9, s. 1359-1368
  • Tidskriftsartikel (refereegranskat)abstract
    • The genetic etiology of intellectual disability remains elusive in almost half of all affected individuals. Within the Solve-RD consortium, systematic re-analysis of whole exome sequencing (WES) data from unresolved cases with (syndromic) intellectual disability (n = 1,472 probands) was performed. This re-analysis included variant calling of mitochondrial DNA (mtDNA) variants, although mtDNA is not specifically targeted in WES. We identified a functionally relevant mtDNA variant in MT-TL1 (NC_012920.1:m.3291T > C; NC_012920.1:n.62T > C), at a heteroplasmy level of 22% in whole blood, in a 23-year-old male with severe intellectual disability, epilepsy, episodic headaches with emesis, spastic tetraparesis, brain abnormalities, and feeding difficulties. Targeted validation in blood and urine supported pathogenicity, with heteroplasmy levels of 23% and 58% in index, and 4% and 17% in mother, respectively. Interestingly, not all phenotypic features observed in the index have been previously linked to this MT-TL1 variant, suggesting either broadening of the m.3291T > C-associated phenotype, or presence of a co-occurring disorder. Hence, our case highlights the importance of underappreciated mtDNA variants identifiable from WES data, especially for cases with atypical mitochondrial phenotypes and their relatives in the maternal line.
  •  
50.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 41-50 av 373
Typ av publikation
tidskriftsartikel (354)
konferensbidrag (10)
forskningsöversikt (4)
recension (3)
annan publikation (2)
Typ av innehåll
refereegranskat (319)
övrigt vetenskapligt/konstnärligt (54)
Författare/redaktör
Kristoffersson, Ulf (18)
Kere, J (14)
Dahl, Niklas (12)
Anderlid, BM (10)
Oldfors, Anders, 195 ... (10)
Wirta, Valtteri (9)
visa fler...
Hillert, J (8)
Syvänen, Ann-Christi ... (8)
Gyllensten, Ulf (8)
van El, Carla G. (8)
Lindblom, A (7)
Ameur, Adam (7)
Darin, Niklas, 1964 (7)
Cornel, Martina C. (7)
Cordier, Christophe (6)
Benitez, J. (6)
Dennis, J (6)
Olsson, T (6)
Kockum, I. (6)
Groop, Leif (6)
Wahlström, Jan, 1939 (6)
Andrulis, IL (6)
Radice, P (6)
Jakubowska, A (6)
Chenevix-Trench, G (6)
Schmutzler, RK (6)
Johansson, Åsa (6)
Tranebjaerg, Lisbeth (6)
Melberg, Atle (6)
Borry, Pascal (6)
Rial-Sebbag, Emmanue ... (6)
Mascalzoni, Deborah, ... (6)
Ingvoldstad, Charlot ... (5)
Perola, Markus (5)
Nordgren, A (5)
Grigelioniene, G (5)
Nordenskjold, M (5)
Alfredsson, L (5)
Rönnblom, Lars (5)
Nevanlinna, H (5)
Stranneheim, Henrik (5)
Rantapää-Dahlqvist, ... (5)
Lindstrand, A (5)
Peltonen, L (5)
Blennow, E (5)
Rosén, Anna, 1975- (5)
Hansson, Mats G. (5)
Evers-Kiebooms, Gerr ... (5)
Pembrey, Marcus (5)
Radojkovic, D (5)
visa färre...
Lärosäte
Karolinska Institutet (189)
Uppsala universitet (121)
Lunds universitet (51)
Umeå universitet (36)
Göteborgs universitet (30)
Kungliga Tekniska Högskolan (25)
visa fler...
Linköpings universitet (18)
Sveriges Lantbruksuniversitet (10)
Chalmers tekniska högskola (7)
Örebro universitet (6)
Stockholms universitet (4)
Jönköping University (2)
Högskolan i Skövde (2)
Handelshögskolan i Stockholm (1)
Marie Cederschiöld högskola (1)
visa färre...
Språk
Engelska (373)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (157)
Naturvetenskap (40)
Samhällsvetenskap (6)
Lantbruksvetenskap (5)
Humaniora (4)
Teknik (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy